GlassScriptPhysician profile
Pranav Diwan
NPI 1306152855
$14,513.29
in general payments reported to CMS, 2019-2025
22 companies · $477 in 2025
The $477 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $214 · 2021: $173 · 2022: $398 · 2023: $6,437 · 2024: $6,614 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $12K · Food and Beverage: $1,528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $12,000.00 |
| Food and Beverage | $1,527.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $12,310.91 | 2022-2024 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Novartis Pharmaceuticals Corporation | $410.57 | 2022-2024 | |
| Shockwave Medical, INC | $389.99 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $360.21 | 2019-2025 | Eliquis, Camzyos |
| Abbott Laboratories | $172.28 | 2020-2025 | Aveir, Jot Dx, Cardiomems |
| Abiomed | $135.96 | 2020 | |
| Cvrx, INC. | $113.58 | 2024-2025 | Barostim Neo System |
| Pfizer INC. | $99.73 | 2019-2023 | |
| Cardiovascular Systems INC. | $82.48 | 2019-2023 | Diamondback Coronary |
| Astrazeneca Pharmaceuticals LP | $70.44 | 2020-2024 | Farxiga |
| Sanofi-Aventis U.S. LLC | $60.85 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $56.97 | 2019-2023 | Lifevest |
| Novo Nordisk INC | $47.25 | 2020-2022 | |
| Amgen INC. | $47.03 | 2019-2022 | |
| Boston Scientific Corporation | $33.11 | 2020-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acist Medical Systems, INC. | $23.98 | 2025 | |
| Daiichi Sankyo INC. | $18.57 | 2022 | |
| Amarin Pharma, INC. | $17.50 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.06 | 2022 | |
| Merck Sharp & Dohme LLC | $16.14 | 2021 | |
| Janssen Pharmaceuticals, INC | $15.47 | 2022 | |
| Medtronic Vascular, INC. | $13.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pranav Diwan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.